U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 100 points on Thursday.
The Dow traded up 0.82% to 43,335.29 while the NASDAQ gained 0.69% to 20,110.81. The S&P 500 also rose, gaining, 0.66% to 6,132.29.
Check This Out: AMD, Taiwan Semiconductor And A Financial Stock On CNBC’s ‘Final Trades’
Leading and Lagging Sectors
Materials shares jumped by 0.9% on Thursday.
In trading on Thursday, real estate stocks fell by 1%.
Top Headline
Walgreens Boots Alliance Inc (NASDAQ:WBA) on Thursday reported better-than-expected earnings for the third quarter on Thursday.
The company posted third-quarter sales of $38.99 billion, up 7.2% year over year (+6.9% on constant currency), beating the consensus of $36.84 billion, reflecting sales growth in the U.S. Retail Pharmacy and International segments. Adjusted EPS was 38 cents, down from 63 cents a year ago, beating the consensus of 34 cents, according to data from Benzinga Pro.
Walgreens Boots Alliance withdrew its 2025 guidance as part of the M&A deal with Sycamore Partners. The merger is expected to close in the fourth quarter of calendar year 2025.
Equities Trading UP
- Cyngn Inc. (NASDAQ:CYN) shares shot up 277% to $18.83 after the company announced it partnered with Nvidia to showcase its autonomous industrial vehicles at Automatica 2025.
- Shares of Ascent Solar Technologies, Inc. (NASDAQ:ASTI) got a boost, surging 113% to $2.4799 after the company entered into a collaborative agreement with NASA.
- Worthington Steel, Inc. (NYSE:WS) shares were also up, gaining 13% to $29.69 as the company reported stronger-than-expected financial results for the fourth quarter.
Equities Trading DOWN
- Globavend Holdings Limited (NASDAQ:GVH) shares dropped 74% to $0.1835 after the company announced the pricing of a $15 million offering of 21,739,130 shares at $0.69 per share.
- Shares of Altimmune, Inc. (NASDAQ:ALT) were down 56% to $3.4133 after the company announced topline results from the IMPACT Phase 2b trial of Pemvidutide in the treatment of MASH.
- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) was down, falling 54% to $0.3502 after the company announced a $10 million public offering of 20 million shares and dual warrants at a combined price of $0.50 per share and accompanying warrants.
Commodities
In commodity news, oil traded up 1.3% to $65.79 while gold traded down 0.2% at $3,335.10.
Silver traded up 0.9% to $36.420 on Thursday, while copper rose 3% to $5.1200.
Euro zone
European shares were mostly higher today. The eurozone's STOXX 600 rose 0.01%, while Spain's IBEX 35 Index rose 0.03%. London's FTSE 100 rose 0.23%, Germany's DAX 40 gained 0.38% and France's CAC 40 slipped 0.11% during the session.
Asia Pacific Markets
Asian markets closed mixed on Thursday, with Japan's Nikkei gaining 1.65%, Hong Kong's Hang Seng Index falling 0.61%, China's Shanghai Composite falling 0.22% and India's BSE Sensex rising 1.21%.
Economics
- The U.S. economy shrank at an annualized rate of 0.5% in the first quarter, compared to a 0.2% decline as per the second estimate.
- U.S. initial jobless claims declined by 10,000 from the previous week to 236,000 in the week ended June 21.
- U.S. durable goods orders climbed by 16.4% month-over-month to $343.6 billion in May compared to a revised 6.6% decline in April.
- The U.S. trade deficit in goods increased to $96.6 billion in May from $87.0 billion in the previous month, and versus market estimates of an $88.5 billion gap.
- The Chicago Fed National Activity Index rose to –0.28 in May compared to a revised reading of –0.36 in April.
- U.S. wholesale inventories declined 0.3% month-over-month to $905.4 billion in May following a revised 0.1% gain in April.
Now Read This:
Photo: Shutterstock
